Topic
Louisiana has become the first U.S. state to classify two FDA-approved abortion-inducing drugs — mifepristone and misoprostol — as Schedule IV controlled substances, placing them alongside Xanax and Valium under a law signed by Republican Gov. Jeff Landry.
25 May 2024
